Suppr超能文献

钒灰制剂的合成与表征

Synthesis and characterization of Vanga bhasma.

作者信息

Kale Babita, Rajurkar Nilima

机构信息

Department of Chemistry, Savitribai Phule Pune University, Pune 411 007, India.

Department of Chemistry, Savitribai Phule Pune University, Pune 411 007, India.

出版信息

J Ayurveda Integr Med. 2019 Apr-Jun;10(2):111-118. doi: 10.1016/j.jaim.2017.05.003. Epub 2018 Jan 5.

Abstract

BACKGROUND

Bhasmas are unique Ayurvedic organometallic preparations used for medicinal purpose. Quality of bhasma depends upon quality of starting materials, processing ingredients, meticulous trituration and heating cycle. In Ayurveda, Vanga bhasma is traditional Indian medicine which is an organometallic preparation treated with plant extract. It is especially used in the treatments of diseases related to gastrointestinal tract and genitor urinary system. However detailed characterization studies after synthesis are important which shows authenticity of product.

OBJECTIVE

The present study deals with the preparation of Vanga bhasma according to the procedure mentioned in the Ayurvedic literature. Synthesized bhasma was characterized by various analytical techniques and also compared with commercial sample.

MATERIAL AND METHOD

Different steps involved in synthesis of Vanga bhasma include shodhan (purification/detoxification), jaran (heating and stirring), bhavan (levigation) and maran (incineration). Bhasma was incinerated (maran process) by traditional method of heating as well as using muffle furnace. These two products obtained from Maran (incineration) and commercial sample were analyzed for quality control checks, on the parameters described in Ayurvedic texts as well as modern techniques such as TEM, SEM, EDX, XRD, DLS and FTIR were done to find out the nature and form of the drug prepared. The in vitro gastric and gastrointestinal (pancreatic) bioaccessibility of Bhasma were also determined.

RESULTS

The study reveals that the synthesized Bhasma was converted into its nontoxic oxide form and had a highly reduced particle size observed from SEM images. These studies reveal that Vanga Bhasma prepared by traditional method of heating (Sn1) has 50% nanoparticles (150-300 nm range) that prepared by using electric muffle furnace (Sn2) has 100% nanoparticles (50-100 nm range) while commercial samples (Sn3) has 50% nanoparticles (100-300 nm range).

CONCLUSION

The study confirmed the formation of organometallic compound (SnO) at the end of the manufacturing process. The percentage bioaccessibility for gastrointestinal digestion is more than the gastric digestion. Hence, it is concluded that Vanga Bhasma can be useful nanomedicine.

摘要

背景

煅灰是阿育吠陀医学中用于药用的独特有机金属制剂。煅灰的质量取决于起始原料的质量、加工成分、精细研磨和加热周期。在阿育吠陀医学中,万加煅灰是一种传统的印度药物,是一种用植物提取物处理的有机金属制剂。它特别用于治疗与胃肠道和生殖泌尿系统相关的疾病。然而,合成后的详细表征研究很重要,这显示了产品的真实性。

目的

本研究按照阿育吠陀文献中提到的程序制备万加煅灰。通过各种分析技术对合成的煅灰进行表征,并与市售样品进行比较。

材料与方法

万加煅灰合成过程中的不同步骤包括净化(提纯/解毒)、加热搅拌、研磨和煅烧。煅灰通过传统加热方法以及使用马弗炉进行煅烧(煅烧过程)。对从煅烧(煅烧过程)获得的这两种产品和市售样品进行质量控制检查分析,按照阿育吠陀文献中描述的参数以及现代技术如透射电子显微镜(TEM)、扫描电子显微镜(SEM)、能谱仪(EDX)、X射线衍射仪(XRD)、动态光散射(DLS)和傅里叶变换红外光谱(FTIR)来确定所制备药物的性质和形态。还测定了煅灰在体外胃和胃肠道(胰腺)的生物可及性。

结果

研究表明,合成的煅灰转化为其无毒氧化物形式,从扫描电子显微镜图像观察到其粒径大幅减小。这些研究表明,通过传统加热方法制备的万加煅灰(Sn1)有50%的纳米颗粒(粒径范围为150 - 300纳米),使用马弗炉制备的(Sn2)有100%的纳米颗粒(粒径范围为50 - 100纳米),而市售样品(Sn3)有50%的纳米颗粒(粒径范围为100 - 300纳米)。

结论

该研究证实了在制造过程结束时形成了有机金属化合物(SnO)。胃肠道消化的生物可及性百分比高于胃消化。因此,得出结论,万加煅灰可能是一种有用的纳米药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/6598822/761882343c0b/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验